SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-035376
Filing Date
2024-03-22
Accepted
2024-03-22 16:22:29
Documents
13
Period of Report
2024-03-22
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K revb-20240322.htm   iXBRL 8-K 44196
2 EX-99.1 revb-ex99_1.htm EX-99.1 150248
3 GRAPHIC img220778470_0.jpg GRAPHIC 18521
  Complete submission text file 0000950170-24-035376.txt   384752

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT revb-20240322.xsd EX-101.SCH 48893
16 EXTRACTED XBRL INSTANCE DOCUMENT revb-20240322_htm.xml XML 6943
Mailing Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122
Business Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122 650-800-3717
REVELATION BIOSCIENCES, INC. (Filer) CIK: 0001810560 (see all company filings)

IRS No.: 843898466 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39603 | Film No.: 24775555
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)